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a  b  s  t  r  a  c  t
A  previous  study  demonstrated  the  existence  of a  natural  resistance  to  feline  infectious  peritonitis  virus
(FIPV) among  36%  of randomly  bred laboratory  cats.  A genome  wide  association  study  (GWAS)  on  this
population  suggested  that resistance  was  polygenic  but  failed  to  identify  any  strong  speciﬁc  associations.
In  order  to enhance  the  power  of GWAS  or whole  genome  sequencing  to identify  strong  genetic  asso-
ciations,  a decision  was  made  to positively  select  for resistance  over  three  generations.  The  inbreeding
experiment  began  with  a genetically  related  parental  (P) population  consisting  of  three  toms  and  four
queens  identiﬁed  from  among  the  survivors  of  the  earlier  study  and  belonging  to  a closely  related  sub-
group  (B).  The  subsequent  effects  of inbreeding  were  measured  using  42 genome-wide  STR  markers.
P  generation  cats  produced  57  ﬁrst  ﬁlial  (F1)  kittens,  only  ﬁve  of  which  (9.0%)  demonstrated  a naturalositive selection
nbreeding
resistance  to FIPV  infection.  One  of  these  ﬁve  F1  survivors  was then  used  to  produce  six F1/P-backcrosses
kittens,  only  one  of  which  proved  resistant  to FIP.  Six  of  eight  of  the  F1 and F1/P  survivors  succumbed
to a secondary  exposure  4–12  months  later.  Therefore,  survival  after  both  primary  and  secondary  infec-
tion was  decreased  rather  than increased  by  positive  selection  for resistance.  The  common  genetic  factor
associated  with  this  diminished  resistance  was  a loss  of heterozygosity.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
Feline infectious peritonitis (FIP) is enzootic in virtually all
ultiple cat populations that involve either kitten production or
ousing (Pedersen, 2014). Eighty percent of FIP cases occur in
ats younger than two years and 50% in kittens under 7 months
f age (Worthing et al., 2012). The FIP virus (FIPV) is a result
f a series of unique and common internally occurring muta-
ions in the ubiquitous and largely non-pathogenic feline enteric
oronavirus (FECV) (Pedersen, 2014; Pedersen et al., 2008). FIP
ases almost always occur as mini-enzootics, with the incidence
n some catteries varying from 0 to 10% over ﬁve years (Foley et al.,
997). Shelters suffer a similar pattern of disease. This variability
n incidence reﬂects a complex web of potential risk factors. The
trongest risk factors are: (1) severity of exposure to feline enteric
oronavirus (FECV) (Foley et al., 1997); (2) the likelihood that FECV
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will undergo speciﬁc mutations that alter tropism from enterocytes
to peritoneal macrophages (Pedersen, 2014); (3) maternal immu-
nity to FECV infection (Pedersen et al., 2008); (4) the age at which
a cat is confronted with FIPV (Pedersen et al., 2014); (5) the type of
environment, husbandry procedures, and exposure to other infec-
tious agents (Foley et al., 1997; Pedersen et al., 1977, 2004; Poland
et al., 1996), and (6) heritable predisposition (Foley et al., 1997;
Golovko et al., 2013).
The role of genetic factors in FIP resistance/susceptibility is
based on both indirect and direct observations. Pedigreed cats
are more likely to develop FIP than random-bred cats and cer-
tain breeds are also more severely affected than others (Bell et al.,
2006; Norris et al., 2012; Pesteanu-Somogyi et al., 2006; Worthing
et al., 2012). Heritability accounted for 50% of the incidence among
Persian catteries that were studied over a ﬁve year period (Foley
et al., 1997). Genome wide association studies (GWAS) conﬁrmed
that genetic susceptibility to FIP in Birman cats was  highly poly-
morphic and genetic associations varied depending on the age of
cats tested (Golovko et al., 2013). A recent study also found that
36% of laboratory cats from a speciﬁc breeding colony were also
naturally resistant to FIPV infection, although GWAS was again
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table  1
Parental relationships of cats used to create F1 and F1-backcross generations of kittens and the results of primary infection with FIPV.
Results of infection
Cat-ID #’s # of cats FIP No-FIP Group Sire-ID Sire group Dam-ID Dam group
13P01-P06 5 5 0 BB 11-149 B 10-145 B
13P08-P09 2 1 1 BB 11-149 B 10-211 B
14P09-P10 2 2 0 BB 11-149 B 11-147 B
13P29-P33 5 5 0 BB 11-166 B 10-145 B
13P34-P37 4 4 0 BB 11-166 B 10-211 B
13P38-P41 4 4 0 BB 11-166 B 10-213 B
13P15-P20 6 5 1 BB 11-166 B 11-147 B
14P04-P08 5 5 0 BB 11-225 B 10-145 B
13P10-P14 5 5 0 BB 11-225 B 10-213 B
13-P07 1 0 1 BB 11-149 B 10-211 B
12A5-A8 4 4 0 BB 11-149 B 10-213 B
12-1A-4A 4 3 1 BB 11-166 B 10-145 B
14P18-P20 3 3 0 BB 11-166 B 10-211 B
14P13-P17 5 4 1 BB 11-166 B 10-213 B
12A9-A10 2 2 0 BB 11-225 B 11-147 B
14P21-P24 3 2 1 B/BB 11-166 B 12-4A BB
14P01-P03 3 3 0 B/BB 
Total  63 57 6























Population B formed the largest and tightest cluster and threeandom bred speciﬁc pathogen free cats that had been experimentally infected with
IPV as documented in a previous study (Pedersen et al., 2014).
nable to identify strong genetic associations (Pedersen et al.,
014).
The present study was an offshoot of earlier experiments with
IPV infection among randomly bred laboratory cats (Pedersen
t al., 2014). Because of difﬁculties in collecting sufﬁcient DNA sam-
les from the ﬁeld, a decision was made to enhance the likelihood
f identifying FIP protective genotypes by inbreeding FIPV resistant
ats resulting from previous laboratory studies. Although immunity
o infectious diseases in humans is polygenic, speciﬁc polymor-
hisms associated with risk have been identiﬁed for a number of
mportant infections (Chapman and Hill, 2012). The basic premise
as that if resistance traits were of limited number and of sufﬁcient
trength that it should be possible to concentrate these genotypes
y positive selection, making it easier to deﬁne them by GWAS or
hole genome sequencing. The expectation was that inbreeding
IPV resistant cats would further decrease mortality in their kittens.
. Materials and methods
.1. Experimental animals
Feline coronavirus free randomly bred, cats used for this study
ere obtained from the breeding colony of the Feline Nutrition and
et Care Center and housed in their Feline Research Laboratory. All
nimal experiments were in compliance with relevant regulatory11-225 B 12-4A BB
standards as documented in UC Davis IACUC protocols #16988 and
#18215.
2.2. FIPV infection and disease monitoring
Sixty three kittens 6 months of age were experimentally infected
with FIPV by the intraperitoneal route. The origins of Type I
FIPV–m3c2 and the preparation of cell-free infectious inoculates
have been published (Pedersen et al., 2012, 2014). Affected cats
were either euthanized with an intravenous overdose of pento-
barbital and phenytoin sodium or transferred to an antiviral drug
treatment protocol (Kim et al., 2015) when clinical and laboratory
signs indicated that their infection would be inevitably fatal, usually
within 3–4 weeks of exposure (Pedersen et al., 2015).
2.3. Genetic testing
The genetic relationship of cats from the P, F1 and F1/P backcross
generations was  conﬁrmed by using allele frequencies obtained
from 42 microsatellites across the cat genome (Menotti-Raymond
et al., 2003, 2009). Genotyping was conducted by the Veteri-
nary Genetics Laboratory, UC Davis, and data were analyzed using
STR and analysis software (Toonen and Hughes, 2002). Population
genetic and principal coordinate analyses (PCoA) were conducted
using GenAIEX 6.5 (Peakall and Smouse, 2012). The results of
genome wide association studies (GWAS) and multi-dimensional
scaling (MDS) were described in an earlier publication (Pedersen
et al., 2014).
3. Results
3.1. Breeding scheme for P, F1, and F2 generation cats
Seventy seven of 111 cats described in an earlier study were sus-
ceptible to FIPV infection and 34 were resistant; DNA from 107 of
these cats was assessed by GWAS and MDS  as previously reported
(Pedersen et al., 2014). The cats were differentiated into three
genetically distinct subpopulations labeled A–C when examined by
MDS  (Fig. 1). The 34 cats that resisted FIPV challenge-exposure were
randomly segregated among the three subpopulations (Fig. 1).toms and four queens were selected from among this group to
create a parental (P) generation. These seven cats produced 57 F1
kittens between them (Table 1). One F1 female (12-4A) was  bred
N.C. Pedersen et al. / Veterinary Immunology a
Table  2
Genetic assessment of P, F1 and F1-backcross cats using 42 genome-wideSTR loci.
Genetic values include average alleles/locus (Aa), average effective alleles/locus (Ae),
and observed heterozygosity (Ho).
Generation # Cats Aa Ae Ho
P Mean 7 3.206 2.464 0.752
SE 0.192 0.150 0.048
F1  Mean 57 3.206 2.443 0.538
SE 0.192 0.151 0.033
F1/P Mean 6 2.294 1.770 0.446
SE 0.116 0.079 0.043
Table 3
The number and percent of genome wide STR loci with homozygous alleles.
Generation # Homozygous loci % Loci
P Mean 8.43 0.25
SD 1.62 0.05


































tB/BB Mean 18.83 0.55
SD 6.59 0.19
nce with her father (11-166) and once with a full brother of the
ather (11-225) to produced six F1/P-backcross kittens (Table 1).
he breeding program was terminated at this point based on the
esults of subsequent FIPV challenge-exposures. Table 2 provides
 genetic assessment of the P, F1 and F1/P backcross populations
ased on a panel of 42 STR loci. The average alleles/locus (Aa) and
he average effective alleles/locus (Ae) remained the same in the
 and F1 cats, but decreased in the F1/P backcrosses. Observed
eterozygosity (Ho) decreased from the P to F1/P generations,
eﬂecting the inbreeding. An increase in genome-wide homozygos-
ty based on alleles at each of 42 genome-wide STR loci was  also
bserved between the P and F1/P backcross generations (Table 3).
.2. Resistance of F1 and F1/P backcross generation kittens to
rimary FIPV challenge-exposure
Fifty seven F1 kittens were produced and 52 (91%) developed
erminal signs of FIP by 3–4 weeks post-infection. Five of six (83%)
1/P-backcross kittens also developed terminal FIP upon primary
xposure (Table 2). The mortality among F1 and F1/P backcross
ats to primary FIPV challenge exposure was signiﬁcantly higher
han the 21/34 (62%) mortality among B group cats that received a
rimary challenge-exposure at a similar age (P = 0.0011, two-tailed
isher’s exact test).
.3. Resistance of F1 and F1/P backcross generation kittens to
econdary FIPV challenge-exposure
Eight cats from the F1 and F1/P generations were re-challenged
ith FIPV 4–12 months after resisting primary infection and 6/8
75%) succumbed to FIP. This mortality was higher than that
bserved following secondary challenge-exposure of group B cats
hat survived primary infection (4/13 = 31%), although the differ-
nce was signiﬁcant only at P = 0.08 (two tailed Fisher’s exact test).
. Discussion
The present study was based on the assumption that resistance
actors to FIPV infection in this particular colony of laboratory cats
ould be amenable to positive selection, thus yielding a small
olony of inbred cats that would be much more resistant to FIPV
han their parents and grandparents. These inbred cats wouldnd Immunopathology 171 (2016) 17–20 19
emphasize regions of the genome involved in FIPV resistance, a
situation used to great advantage to identify both simple and poly-
genic traits in highly inbred breeds of dogs (Hedrick and Andersson,
2011; Ostrander et al., 2008). The outcome of the breeding study
confounded these expectations and actually led to F1 and F1/P back-
cross kittens that appeared to be signiﬁcantly more susceptible to
experimental FIPV infection than their progenitors, both to primary
and secondary challenge-exposures.
The only apparent genetic association with decreased resistance
was a loss of heterozygosity. The effect of lost heterozygosity can be
best explained by models of autoimmune and infectious diseases
in humans (Barreiro and Quintana-Murci, 2010; Goris and Liston,
2012). These models implicate numerous genetic polymorphisms
within the MHC  and other parts of the genome. Each polymorphism
contributes small degrees of genetic risk or protection against dis-
ease that is often below the level of detectability by GWAS, and with
no single risk factor being essential. A number of different polymor-
phisms may  also lead to the same clinical outcome. In this scenario,
a loss of genetic diversity could actually decrease the number of
resistance-associated options available to the host.
What are the observations among pedigreed cats that implicate
a loss of heterozygosity in FIP resistance or susceptibility? Unfor-
tunately, no one has directly studied the relationship between FIP
incidence and inbreeding, although a number of cat breeds are
known to be highly inbred (Lyons et al., 2008) and some breeds
appear to be more susceptible to FIP than others (Bell et al., 2006;
Norris et al., 2012; Pesteanu-Somogyi et al., 2006; Worthing et al.,
2012). The use of certain sires has been linked to a higher incidence
of FIP among their offspring (Foley and Pedersen, 1996), not because
the susceptibility traits are carried only in toms, but because a sin-
gle tom produces far more offspring than a single queen. Multiple
cases of FIP within the same litter are frequently observed. There-
fore, the results of this study conﬁrm both the genetic complexity
of FIPV resistance and the widely recommended practice of avoid-
ing the use of cats with progeny dying of FIP for breeding programs
in pedigreed catteries.
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